To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Adipose-Derived MSCs vs Triamcinolone for Knee Osteoarthritis

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2025

Adipose-Derived MSCs vs Triamcinolone for Knee Osteoarthritis

Vol: 307| Issue: 10| Number:103| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effects of Ultrasound-Guided Corticosteroid Injection Compared to Mesenchymal Stem Cell Injection in Patients With Grade II and III Knee Osteoarthritis: A Randomized Double-Blind Controlled Trial.

Am J Phys Med Rehabil . 2025 Jul 1;104(7):646-653.

Contributing Authors:
M ZoghAli N Amini A Babaei-Ghazani B Forogh MT Joghataei MR Babaei M Rikhtehgar K Abdolmaleki

Synopsis

Sixty patients with grade II–III knee osteoarthritis were randomized to receive adipose-derived mesenchymal stem cells (MSCs) (n=30) or triamcinolone (n=30). Primary outcome: pain (VAS). Secondary outcomes: WOMAC subscales (stiffness, pain, physical function), knee ROM, and MRI parameters. Outcomes were assessed at baseline, 2, 4, and 24 weeks. Overall, pain trajectories differed by group with a b...

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue